A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: capecitabine|DRUG: S1 generic
Sponsor: Fudan University